ArticleAngiogenesis2018

Selective IKK2 inhibitor IMD0354 disrupts NF-κB signaling to suppress corneal inflammation and angiogenesis.

Anton Lennikov et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.